UBC Faculty Research and Publications

Using Best Evidence for the Management of Hypertension University of British Columbia. Therapeutics Initiative

Description

Therapeutics Letter 106 examines Cochrane systematic review evidence on antihypertensives for treatment of high blood pressure. Conclusions: Antihypertensive drug treatment modestly reduces mortality and morbidity in people ≥ 60 with moderate to severe hypertension (>160/100). Low-dose thiazide diuretics are the best drug class for starting therapy. In mild hypertension (140-159/90-99) antihypertensive drugs have not been proven to reduce mortality and morbidity. Blood pressure treatment targets should be those used in RCTs (<140-160/90-100), as lower BP targets have not been shown to have a net health benefit.

Item Citations and Data

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International